Actionable news
All posts from Actionable news
Actionable news in INO: Inovio Pharmaceuticals, Inc.,

Inovio Announces Proposed Public Offering of Common Stock

PLYMOUTH MEETING, Pa., July 18, 2017 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (INO) today announced that it intends to offer and sell $75.0 million of shares of its common stock in an underwritten public offering. Inovio expects to grant the underwriters an option to purchase up to an additional $11.25 million of shares of its common stock on the same terms and conditions. All of the shares are being offered by Inovio. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

Inovio anticipates using the net proceeds from this offering for general corporate purposes, including clinical trial expenses, research and development expenses, general and administrative expenses, manufacturing expenses and other business development activities.

Citigroup, Piper Jaffray & Co. and RBC Capital Markets are acting as joint book-running managers for the offering.

The shares of common stock described above are being offered by Inovio pursuant to a shelf registration statement filed by Inovio with the Securities and Exchange Commission (SEC) that was declared effective on June 5, 2015. A preliminary prospectus supplement and accompanying prospectus relating to the offering will be filed with the SEC and will be available on the SEC's website located at Copies of the preliminary prospectus supplement and the accompanying prospectus relating to the offering, when available, may be obtained from...